Titlebook: Breast Cancer; Nuclear Medicine in Emilio Bombardieri,Luca Gianni,Gianni Bonadonna (C Book 2008 Springer-Verlag Berlin Heidelberg 2008 Bre

輕觸

Bernhard Felderer,Stefan Homburgappropriate postoperative treatments. Nodal status, tumor size, tumor grade, age and HER2 expression are universally accepted as important factors to define risk categories. Newer factors such as uPA/PAI-1, cyclin-E and other proliferative indices and the gene expression profile are promising and wi

有害

FELON

嬉耍

Axillary Lymph Node Status Evaluation in Breast Cancer Patients: Role of SPECT and Pinhole SPECT wisiveness and morbidity. However, ALND may not be necessary in many cases, in particular in early stage carcinomas with tumor size <10 mm and even more so when axillary clinical examination is negative, since in this case the percentage of lymph node metastases is very low. Moreover, even when axilla

OFF

外貌

PET Imaging of Breast Cancer Molecular Biomarkers,h into disease-specific biochemical processes have advanced the development of molecular biomarkers as targets for molecular imaging..A biomarker can be defined as a measurable variable of a molecular, biological or functional process that can also be used as a measure of pharmacologic response to t

eustachian-tube

引起痛苦

FDG-PET in Monitoring Therapy of Breast Cancer,onitoring chemotherapy in breast cancer..Whole body imaging with fluorine-18 deoxyglucose PET (FDG-PET) has gained widespread acceptance for the staging and restaging of breast cancer (Biersack et at. 2001; Kostakoglu and Goldsmith 2003; Grahek et al. 2004). Another significant indication for FDG-PE

山羊

FDG-PET and Tumour Marker Tests for the Diagnosis of Breast Cancer,n screening and early diagnosis; it has an established role in the diagnosis of recurrences; it has an established role in therapy monitoring, alone or in association with other diagnostic tools; it is still under study as a predictor of response to therapy. Several international guidelines help phy

Conserve

Advantages and Limitations of FDG PET 16 in the Follow-Up of Breast Cancer, imaging methods..Limitations of FDG PET in the follow-up of breast cancer patients include the relatively low detection rate of bone metastases, especially in case of sclerotic subtype, and the relatively high rate of false-positive results. The rather low specificity of FDG PET can be improved/inc